These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 15935100)

  • 1. Preponderance of the oncogenic V599E and V599K mutations in B-raf kinase domain is enhanced in melanoma cutaneous/subcutaneous metastases.
    Deichmann M; Thome M; Benner A; Kirschner M; Hassanzadeh J; Kurzen H
    BMC Cancer; 2005 Jun; 5():58. PubMed ID: 15935100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preponderance of the oncogenic V599E and V599K mutations in the B-raf kinase domain is enhanced in melanoma lymph node metastases.
    Kirschner M; Helmke B; Starz H; Benner A; Thome M; Deichmann M
    Melanoma Res; 2005 Oct; 15(5):427-34. PubMed ID: 16179870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B-raf exon 15 mutations are common in primary melanoma resection specimens but not associated with clinical outcome.
    Deichmann M; Thome M; Benner A; Näher H
    Oncology; 2004; 66(5):411-9. PubMed ID: 15331929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The oncogenic B-raf V599E mutation occurs more frequently in melanomas at sun-protected body sites.
    Deichmann M; Krahl D; Thome M; Wüst K; Hassanzadeh J; Helmke B
    Int J Oncol; 2006 Jul; 29(1):139-45. PubMed ID: 16773193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of BRAF mutations in uveal melanoma.
    Rimoldi D; Salvi S; Liénard D; Lejeune FJ; Speiser D; Zografos L; Cerottini JC
    Cancer Res; 2003 Sep; 63(18):5712-5. PubMed ID: 14522889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of B-RAF and N-RAS mutations in human melanoma.
    Goydos JS; Mann B; Kim HJ; Gabriel EM; Alsina J; Germino FJ; Shih W; Gorski DH
    J Am Coll Surg; 2005 Mar; 200(3):362-70. PubMed ID: 15737846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tandem BRAF mutations in primary invasive melanomas.
    Thomas NE; Alexander A; Edmiston SN; Parrish E; Millikan RC; Berwick M; Groben P; Ollila DW; Mattingly D; Conway K
    J Invest Dermatol; 2004 May; 122(5):1245-50. PubMed ID: 15140228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The RAS-BRAF kinase pathway is not involved in uveal melanoma.
    Kiliç E; Brüggenwirth HT; Verbiest MM; Zwarthoff EC; Mooy NM; Luyten GP; de Klein A
    Melanoma Res; 2004 Jun; 14(3):203-5. PubMed ID: 15179189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum and Frequency of BRAF Mutations in Skin Melanomas in the Dalmatian Region of Croatia.
    Bezić J; Tomić I; Pavić M
    Acta Dermatovenerol Croat; 2024 Mar; 32(1):75-76. PubMed ID: 38946192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of V599E BRAF mutations in desmoplastic melanomas.
    Davison JM; Rosenbaum E; Barrett TL; Goldenberg D; Hoque MO; Sidransky D; Westra WH
    Cancer; 2005 Feb; 103(4):788-92. PubMed ID: 15641040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRAF mutations in metastatic melanoma: a possible association with clinical outcome.
    Kumar R; Angelini S; Czene K; Sauroja I; Hahka-Kemppinen M; Pyrhönen S; Hemminki K
    Clin Cancer Res; 2003 Aug; 9(9):3362-8. PubMed ID: 12960123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of BRAF oncogene mutation and clinical relevance for primary cutaneous melanomas.
    Shinozaki M; Fujimoto A; Morton DL; Hoon DS
    Clin Cancer Res; 2004 Mar; 10(5):1753-7. PubMed ID: 15014028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutant V599EB-Raf regulates growth and vascular development of malignant melanoma tumors.
    Sharma A; Trivedi NR; Zimmerman MA; Tuveson DA; Smith CD; Robertson GP
    Cancer Res; 2005 Mar; 65(6):2412-21. PubMed ID: 15781657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BRAF kinase gene V599E mutation in growing melanocytic lesions.
    Loewe R; Kittler H; Fischer G; Faé I; Wolff K; Petzelbauer P
    J Invest Dermatol; 2004 Oct; 123(4):733-6. PubMed ID: 15373778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The V599E BRAF mutation is uncommon in biliary tract cancers.
    Goldenberg D; Rosenbaum E; Argani P; Wistuba II; Sidransky D; Thuluvath PJ; Hidalgo M; Califano J; Maitra A
    Mod Pathol; 2004 Nov; 17(11):1386-91. PubMed ID: 15181454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation analysis of the EGFR-NRAS-BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma.
    Akslen LA; Puntervoll H; Bachmann IM; Straume O; Vuhahula E; Kumar R; Molven A
    Melanoma Res; 2008 Feb; 18(1):29-35. PubMed ID: 18227705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.
    Reifenberger J; Knobbe CB; Sterzinger AA; Blaschke B; Schulte KW; Ruzicka T; Reifenberger G
    Int J Cancer; 2004 Apr; 109(3):377-84. PubMed ID: 14961576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyrophosphorolysis detects B-RAF mutations in primary uveal melanoma.
    Maat W; Kilic E; Luyten GP; de Klein A; Jager MJ; Gruis NA; Van der Velden PA
    Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):23-7. PubMed ID: 18172070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Somatic mitochondrial mutations in melanoma resection specimens.
    Deichmann M; Kahle B; Benner A; Thome M; Helmke B; Näher H
    Int J Oncol; 2004 Jan; 24(1):137-41. PubMed ID: 14654950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous melanoma subtypes show different BRAF and NRAS mutation frequencies.
    Saldanha G; Potter L; Daforno P; Pringle JH
    Clin Cancer Res; 2006 Aug; 12(15):4499-505. PubMed ID: 16899595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.